The words on a treatment page.
These medicine-status notes are dated September 26, 2026.
- Peptide
- Peptides are small chains of building blocks. Proteins are larger chains made from those same blocks. Insulin is one example of a peptide.
- Telehealth
- Telehealth is a visit at a distance, such as care by video rather than in the same room.
- Compounding
- A pharmacist or doctor may make medicine for a patient's particular needs; this is called compounding.
- FDA approval
- Before granting approval for a stated use, the Food and Drug Administration (FDA), the US agency for drugs, reviews the particular medicine.
An approved medicine is a specific product.
As of September 26, 2026, approved semaglutide products include Ozempic for type 2 diabetes and Wegovy for weight loss and keeping weight off. Among tirzepatide products, Mounjaro is approved to treat type 2 diabetes; Zepbound has approval for weight management.
These uses go along with changes in eating and physical activity. Some products also have other approved uses, including reducing heart risks.
That approval does not cover every product described as peptide therapy.
Made to order has a different status.
Compounding notes as of September 26, 2026.
For an ordinary compounding pharmacy, federal law calls for a prescription naming the patient and limits the raw ingredients it may use.
The raw ingredient must meet official pharmacy quality standards if those standards exist. If not, it must be an ingredient in an approved drug or appear on FDA's list of allowed extra ingredients.
The ingredient also needs a report of test results and must come from a drug-making site registered with FDA.
Federal law limits routine copying of a ready-made drug. A change that makes a real medical difference for the named patient can matter; a lower price alone does not count.
It can meet a need an approved product cannot, such as leaving out a dye a patient is allergic to.
A pharmacy licence does not give the finished compounded medicine FDA approval.
A label about research offers no plan for care.
Some online sellers put 'for research use only' on their peptide products. Others use 'not for human consumption'. Those words describe a product for laboratory work, not for a person to take.
In letters dated March 31 and August 24, 2026, FDA said some sellers were still marketing those products as drugs for people.
The label did not remove the rules that apply to selling a drug.
Keep the question concrete: which exact product is offered, and what status does it have?
FDA's explanation of compoundingFDA's notes on unapproved weight drugs